// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

A Molecular Analysis of Graft Survival in the INTERHEART Study

P. Halloran - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Retrospective Analysis Evaluating Various Tissue Biopsy Scoring Systems in Predicting Recipient Outcomes Following Transplantation of Extended Criteria Donor Kidneys

A. Hijazi - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Delayed graft function

N/A

Activation of Oxidative Stress-Adoptive Responses during Extended Ex Situ Heart Perfusion

S. Hatami - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An International Multicentre Validation Study of the Toronto Listing Criteria for Pediatric Intestinal Transplant

A. J. Roberts - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An Open-Label Proof-of-Principle Phase 2A Study to Evaluate Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance (ASCOTT)

A. Chruscinski - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Cyclophosphamide

Apoptotic Exosome-Like Vesicles Induce Endothelial Cell Plasticity and Accelerate Allograft Vascular Remodeling

F. Migneault - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Association between Recipient Sex and Risk of Heart Graft Failure

A. Chackowicz - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Automated Histology Lesion Interpretation in Kidney Transplant Biopsies Shows That Pathologists Often Deviate from Banff Guidelines

K. S. Madill-Thomsen - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Chronic antibody mediated rejection

N/A

Calcineurin Inhibitor Holiday for Management of Post Transplant Acute Kidney Injury

S. Sriperumbuduri - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Thrombotic microangiopathy

Basiliximab

Cellular And Molecular Characteristics Of Intra-graft Lymphoid Aggregates In Chronic Lung Allograft Dysfunction

E. Miyamoto - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Change in Estimated Glomerular Filtration Rate and Risk of Allograft Failure in Patients Diagnosed with Active Antibody-Mediated Rejection Following Kidney Transplantation

W. Irish - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Chronic antibody mediated rejection

N/A

Changes in Kidney Function Following Live Donor Nephrectomy

N. N. Lam - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Characterizing the Dominant Phenotype in Kidney Transplant Biopsies: Improving the Prediction of Risk by a Global View of Rejection, Injury, and Atrophy-Fibrosis

P. F. Halloran - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clazakizumab Acts on Endothelial Cells to Limit Antibody Mediated Damage

J. Lion - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

clazakizumab

Clinical Utility of the Edmonton Symptom Assessment System to Screen for Depression and Anxiety in Kidney Transplant Recipients

E. Tang - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Anxiety

N/A

Comparing Antibody-Mediated Rejection with or without Detectable DSA: Similar Pathology and Similar Poor Prognosis

G. Einecke - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Chronic antibody mediated rejection

N/A

Correlation between Gene Expression and Cardiac Function in Ex Vivo Perfused Porcine Hearts

S. Rotich - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Correlation between Gene Expression and Histology in Transbronchial Lung Transplant Biopsies

B. Adam - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Acute lung injury

N/A

Correlation of Donor-Derived Cell-Free DNA with Histology and Molecular Diagnoses of Kidney Transplant Biopsies

I. Moinuddin - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Daily Use of a Muscle Pump Activator Device Reduces Hospitalization and Improves Graft Function Post Transplantation: A Randomized Controlled Trial

W. Xie - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Delayed graft function

N/A

Copyright © 2026. QuantiNova All rights reserved